Jenburkt Pharmaceuticals Equity Shares Admitted Under NSE Permitted to Trade Category
Jenburkt Pharmaceuticals Ltd 路 Others (Uncategorized) 路 22 Sept 2026, 6:50 pm
Jenburkt Pharmaceuticals Equity Shares Admitted Under NSE Permitted to Trade Category Jenburkt Pharmaceuticals informed BSE that its equity shares were admitted to dealings on NSE's Capital Market Segment under the "Permitted to Trade" category effective 17th Aug'26, pursuant to NSE Circular dated 14th Aug'26. The company clarified that it has not applied for an NSE listing; its shares remain listed exclusively on BSE. The trading facility on NSE operates strictly under the exchange's permitted category without separate direct communication or application from the company.
Original exchange filing (PDF)
More announcements from Jenburkt Pharmaceuticals Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Counter Cyclical Investment Pvt Ltd 路 04 Nov 2026
- Outcome of the Board Meeting held today on 03rd November, 2026. 路 03 Nov 2026
- Standalone Unaudited Financial Results for the quarter and half year ended on 30th September, 2026. 路 03 Nov 2026
- Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Standalone Unaudited .... 路 03 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Counter Cyclical Investment Pvt Ltd 路 12 Oct 2026
- Intimation about Resignation of a Senior Management Personnel of the Company. 路 18 Sept 2026
- Re-Appointment of Shri. Dilip H. Bhuta (DIN 01357252) as Whole Time Director and CFO of the Company for the Period of 05 years from 01st April, 2027 to 31st March, 2032, Approved with requisite .... 路 05 Sept 2026
- Submission of consolidated Voting Results and Scrutinizer''s Report on all the Resolutions as set out in the Notice Convening the 41st AGM of the Company held on 04th September, 2026. 路 05 Sept 2026
